Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles.

Joanna KuźmińskaAgnieszka Sobczak Aleksandra Majchrzak-CelińskaIzabela ŻółnowskaAleksandra Gostyńska Barbara Jadach Violetta Krajka-KuzniakAnna JelińskaMaciej Stawny

Published in: Pharmaceutics (2023)

The combination of ETO and CBD is a promising adjuvant therapeutic in the treatment of GBM, and the prepared ETO+CBD-NPs exhibit a high potential for further pharmaceutical formulation development.

Keyphrases

drug delivery
early stage
risk assessment
climate change
human health
bone regeneration